ATC Group: N01BA04 Chloroprocaine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N01BA04 in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N01 Anesthetics
3 N01B Anesthetics, local
4 N01BA Esters of aminobenzoic acid
5 N01BA04 Chloroprocaine

Active ingredients in N01BA04

Active Ingredient Description
Chloroprocaine

Chloroprocaine is procaine in which one of the hydrogens ortho- to the carboxylic acid group is substituted by chlorine. Chloroprocaine, blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse and by reducing the rate of rise of the action potential. Chloroprocaine (like cocaine) has the advantage of constricting blood vessels which reduces bleeding, unlike other local anesthetics like lidocaine.

Related product monographs

Title Information Source Document Type  
AMPRES 10 mg/ml Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
AMPRES 20 mg/ml Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CLOROTEKAL Solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicines in this ATC group

United States (US)

Austria (AT)

Croatia (HR)

Estonia (EE)

Finland (FI)

France (FR)

Ireland (IE)

Israel (IL)

Lithuania (LT)

Netherlands (NL)

Poland (PL)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.